Maxim analyst Michael Diana raised the firm's price target on Diversified Healthcare Trust to $10.50 from $10 and keeps a Buy rating on the shares. In conjunction with its presentation at Nareit's REIT Week, Diversified Healthcarehas announced that it was raising 2026 guidance across-the-board, the analyst tells investors in a research note. Maxim adds it believes that momentum in 2026 will carry into 2027, enhanced by conversions of closed skilled nursing facilities to units for independent living, assisted living, or memory care.
